These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 7990272)
1. Effects of KCA-098 on bone metabolism: comparison with those of ipriflavone. Tsutsumi N; Kawashima K; Nagata H; Tsuyuki J; Itoh F; Arai N; Kojima M; Ujiie A; Endo H Jpn J Pharmacol; 1994 Aug; 65(4):343-9. PubMed ID: 7990272 [TBL] [Abstract][Full Text] [Related]
2. Effect of KCA-098, a new benzofuroquinoline derivative, on bone mineral metabolism. Kojima M; Tsutsumi N; Nagata H; Itoh F; Ujiie A; Kawashima K; Endo H; Okazaki M Biol Pharm Bull; 1994 Apr; 17(4):504-8. PubMed ID: 8069257 [TBL] [Abstract][Full Text] [Related]
3. In vitro effect of KCA-098, a derivative of coumestrol, on bone resorption of fetal rat femurs. Tsutsumi N; Kawashima K; Arai N; Nagata H; Kojima M; Ujiie A; Endo H Bone Miner; 1994 Mar; 24(3):201-9. PubMed ID: 8019207 [TBL] [Abstract][Full Text] [Related]
4. Effects of KCA-012 on bone metabolism in organ culture. Tsutsumi N; Kawashima K; Nagata H; Ujiie A; Endo H Jpn J Pharmacol; 1995 Feb; 67(2):169-71. PubMed ID: 7616692 [TBL] [Abstract][Full Text] [Related]
5. Effect of coumestrol on bone metabolism in organ culture. Tsutsumi N Biol Pharm Bull; 1995 Jul; 18(7):1012-5. PubMed ID: 7581241 [TBL] [Abstract][Full Text] [Related]
6. Effect of KCA-098 on the function of osteoblast-like cells and the formation of TRAP-positive multinucleated cells in a mouse bone marrow cell population. Kawashima K; Inoue T; Tsutsumi N; Endo H Biochem Pharmacol; 1996 Jan; 51(2):133-9. PubMed ID: 8615881 [TBL] [Abstract][Full Text] [Related]
7. Increase in femoral bone mass by ipriflavone alone and in combination with 1 alpha-hydroxyvitamin D3 in growing rats with skeletal unloading. Notoya K; Yoshida K; Tsukuda R; Taketomi S; Tsuda M Calcif Tissue Int; 1996 Feb; 58(2):88-94. PubMed ID: 8998683 [TBL] [Abstract][Full Text] [Related]
8. Effects of ipriflavone administration on bone mass and metabolism in ovariectomized women. Gambacciani M; Spinetti A; Cappagli B; Taponeco F; Felipetto R; Parrini D; Cappelli N; Fioretti P J Endocrinol Invest; 1993 May; 16(5):333-7. PubMed ID: 8320424 [TBL] [Abstract][Full Text] [Related]
9. The effect of ipriflavone (TC-80) on bone resorption in tissue culture. Tsuda M; Kitazaki T; Ito T; Fujita T J Bone Miner Res; 1986 Apr; 1(2):207-11. PubMed ID: 3503539 [TBL] [Abstract][Full Text] [Related]
10. Ipriflavone improves bone density and biomechanical properties of adult male rat bones. Civitelli R; Abbasi-Jarhomi SH; Halstead LR; Dimarogonas A Calcif Tissue Int; 1995 Mar; 56(3):215-9. PubMed ID: 7750027 [TBL] [Abstract][Full Text] [Related]
11. Ipriflavone inhibits bone resorption in intact and ovariectomized rats. Cecchini MG; Fleisch H; Mühibauer RC Calcif Tissue Int; 1997; 61 Suppl 1():S9-11. PubMed ID: 9263609 [TBL] [Abstract][Full Text] [Related]
12. Effect of ipriflavone on bone changes induced by calcium restricted, vitamin D deficient diet in rats. Takenaka M; Nakata M; Tomita M; Nakagawa T; Tsuboi S; Fukase M; Fujita T Endocrinol Jpn; 1986 Feb; 33(1):23-7. PubMed ID: 3720677 [TBL] [Abstract][Full Text] [Related]
13. Effects of ipriflavone on caged layer bone metabolism in vitro and in vivo. Yao J; Zhang J; Hou JF Poult Sci; 2007 Mar; 86(3):503-7. PubMed ID: 17297162 [TBL] [Abstract][Full Text] [Related]
14. Ipriflavone modulates IGF-I but is unable to restore bone in rats. Deyhim F; Smith BJ; Soung DY; Juma S; Devareddy L; Arjmandi BH Phytother Res; 2005 Feb; 19(2):116-20. PubMed ID: 15852487 [TBL] [Abstract][Full Text] [Related]
15. Fructooligosaccharides maximize bone-sparing effects of soy isoflavone-enriched diet in the ovariectomized rat. Mathey J; Puel C; Kati-Coulibaly S; Bennetau-Pelissero C; Davicco MJ; Lebecque P; Horcajada MN; Coxam V Calcif Tissue Int; 2004 Aug; 75(2):169-79. PubMed ID: 15164148 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of parathyroid hormone-stimulated resorption in cultured fetal rat long bones by the main metabolites of ipriflavone. Giossi M; Caruso P; Civelli M; Bongrani S Calcif Tissue Int; 1996 Jun; 58(6):419-22. PubMed ID: 8661483 [TBL] [Abstract][Full Text] [Related]
17. In vitro anti-resorptive activity and prevention of ovariectomy-induced osteoporosis in female Sprague-Dawley rats by ormeloxifene, a selective estrogen receptor modulator. Arshad M; Sengupta S; Sharma S; Ghosh R; Sawlani V; Singh MM J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):67-78. PubMed ID: 15261309 [TBL] [Abstract][Full Text] [Related]
18. Anabolic effect of phosphogenistein and phosphodaidzein on bone components in rat femoral-metaphyseal tissues in vitro. Yamaguchi M; Ma ZJ; Fushimi T J Bone Miner Metab; 2002; 20(3):148-55. PubMed ID: 11984697 [TBL] [Abstract][Full Text] [Related]
19. Suppressive effect of ipriflavone on bone depletion in the experimental diabetic rat: dose response of ipriflavone. Shino A; Tsukuda R; Odaka H; Kitazaki T; Tsuda M; Matsuo T Life Sci; 1988; 42(11):1123-30. PubMed ID: 3347142 [TBL] [Abstract][Full Text] [Related]
20. Similarities and differences between the effects of ipriflavone and vitamin K on bone resorption and formation in vitro. Notoya K; Yoshida K; Shirakawa Y; Taketomi S; Tsuda M Bone; 1995 Apr; 16(4 Suppl):349S-353S. PubMed ID: 7626324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]